Project Grant HT94252410379
Award Date 7/1/24
Completion Date 6/30/26
Dollars Obligated $678K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10065, USA
Similar Awards
- Federal Project Grant Award Summary Rockefeller University received a $1.65 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2026, through July 31, 2029. The award supports investigator-initiated research focused on therapeutic targeting of a commonly inherited breast cancer metastasis driver gene. This three-year project will deliver basic and applied biomedical research outcomes...
- Federal Project Grant Award Summary Rockefeller University received a $100,228 Project Grant award from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398), effective December 1, 2026 through May 31, 2028. The award supports research and training focused on characterizing Multidrug Resistance Protein 1 (MRP1) and developing MRP1-specific inhibitors to overcome chemoresistance in cancer treatment. The project addresses a critical clinical challenge, as...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Sloan-Kettering Institute for Cancer Research a $559,998 Project Grant on June 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to conduct research on therapeutic targeting of RNA processing to enhance anti-melanoma immunotherapy. The two-year project, concluding May 31, 2028, supports investigator-initiated biomedical research designed to advance medical solutions relevant to Service Member...
- The federal Project Grant award of $1,008,313 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The award was granted to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution, to conduct research on melanoma....
- Federal Grant Award Summary Rockefeller University received a $559,596 Project Grant award from the National Cancer Institute (NCI) under the Cancer Biology Research program (CFDA 93.396), effective July 1, 2026 through June 30, 2031. The award supports research to identify limiting mitochondrial metabolites that drive the initiation and progression of primary liver cancers, particularly hepatocellular carcinoma (HCC). The research leverages a proprietary organelle immunopurification technique...
- The federal Project Grant award in the amount of $499,999.00, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), funds research by the Institute of Cancer Research: Royal Cancer Hospital (The) to study the interplay of molecular and spatial architectures with clinical states in prostate cancer. The research project aims to make discoveries that defeat cancer through innovative biomedical research. As a subawardee, the Institute of...
- Federal Grant Award Summary The Sloan-Kettering Institute for Cancer Research received a $176,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025, through August 31, 2026. This award supports research investigating the interactions of mitochondrially encoded Complex I mutations with hypoxia and antitumor immune response in chromophobe renal cell carcinoma. The research aims to advance...
- Federal Grant Award Summary The Defense Health Agency awarded Columbia University's Health Sciences Division a $560,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective September 30, 2026, with completion targeted for September 29, 2028. The award supports research on viruslike particles (VLPs) to generate chimeric antigen receptor (CAR)-expressing phagocytes in vivo for the treatment of AL-amyloidosis. This research initiative leverages...
- Federal Project Grant Award Summary Award Overview Rockefeller University received a $100,228 Project Grant from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398), awarded December 1, 2026, with a completion date of June 30, 2029. The award supports basic cancer research focused on identifying genes that fuel RAS-driven squamous cell carcinomas (SCCs), specifically investigating the genetic and environmental factors that enable cancer stem cells...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $352,000 under the Military Medical Research and Development program (CFDA 12.420) to the Sloan-Kettering Institute for Cancer Research for the project period September 1, 2025, through August 31, 2027. The award supports research focused on augmenting the in vivo efficacy of a novel lanosterol synthase inhibitor in glioblastoma treatment. This research aligns with the DHA's mission to transform healthcare for service...